Login / Signup

Getting the Timing Right: Controlling BCL-2 Inhibition as an Antifibrotic Therapy.

Joseph C CooleyElizabeth F Redente
Published in: American journal of respiratory cell and molecular biology (2024)
Keyphrases
  • pulmonary fibrosis
  • mesenchymal stem cells